NDC 64679-927

Lisinopril

Lisinopril

Lisinopril is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Wockhardt Usa Llc.. The primary component is Lisinopril.

Product ID64679-927_14a98e8a-bb40-4212-8a55-bbd4972ff939
NDC64679-927
Product TypeHuman Prescription Drug
Proprietary NameLisinopril
Generic NameLisinopril
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2007-04-19
Marketing CategoryANDA / ANDA
Application NumberANDA078402
Labeler NameWockhardt USA LLC.
Substance NameLISINOPRIL
Active Ingredient Strength3 mg/1
Pharm ClassesAngiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 64679-927-01

100 TABLET in 1 BOTTLE (64679-927-01)
Marketing Start Date2007-04-19
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 64679-927-05 [64679092705]

Lisinopril TABLET
Marketing CategoryANDA
Application NumberANDA078402
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2007-04-19

NDC 64679-927-03 [64679092703]

Lisinopril TABLET
Marketing CategoryANDA
Application NumberANDA078402
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2007-04-19

NDC 64679-927-01 [64679092701]

Lisinopril TABLET
Marketing CategoryANDA
Application NumberANDA078402
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2007-04-19

NDC 64679-927-02 [64679092702]

Lisinopril TABLET
Marketing CategoryANDA
Application NumberANDA078402
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2007-04-19

Drug Details

Active Ingredients

IngredientStrength
LISINOPRIL2.5 mg/1

OpenFDA Data

SPL SET ID:e927801e-5de4-44f9-b543-789c093de655
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 197884
  • 314077
  • 205326
  • 314076
  • 311353
  • 311354
    • UPC Code
  • 0364679953051
  • 0364679929063
  • 0364679928059

    • Pharmacological Class

    • Angiotensin Converting Enzyme Inhibitor [EPC]
    • Angiotensin-converting Enzyme Inhibitors [MoA]

    Medicade Reported Pricing

    64679092705 LISINOPRIL 2.5 MG TABLET

    Pricing Unit: EA | Drug Type:

    64679092701 LISINOPRIL 2.5 MG TABLET

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Lisinopril" or generic name "Lisinopril"

    NDCBrand NameGeneric Name
    0143-1266LisinoprilLisinopril
    0143-1267LisinoprilLisinopril
    0143-1268LisinoprilLisinopril
    0143-1270LisinoprilLisinopril
    0143-9713LisinoprilLisinopril
    0143-9714LisinoprilLisinopril
    0143-9715LisinoprilLisinopril
    0185-0025lisinoprillisinopril
    0185-0101lisinoprillisinopril
    0185-0102lisinoprillisinopril
    0185-0103lisinoprillisinopril
    0185-0104lisinoprillisinopril
    0185-0602lisinoprillisinopril
    0185-0605lisinoprillisinopril
    0185-0610lisinoprillisinopril
    0185-0620lisinoprillisinopril
    0185-0630lisinoprillisinopril
    0185-0640lisinoprillisinopril
    0185-5400lisinoprillisinopril
    0378-2072Lisinoprillisinopril
    0378-2073Lisinoprillisinopril
    0378-2074Lisinoprillisinopril
    0378-2075Lisinoprillisinopril
    0378-2076Lisinoprillisinopril
    68001-270lisinoprillisinopril
    68001-271lisinoprillisinopril
    68001-267lisinoprillisinopril
    68001-272lisinoprillisinopril
    68001-334LisinoprilLisinopril
    68001-268lisinoprillisinopril
    68001-333LisinoprilLisinopril
    68001-335LisinoprilLisinopril
    68001-337LisinoprilLisinopril
    68001-269lisinoprillisinopril
    68001-336LisinoprilLisinopril
    68001-332LisinoprilLisinopril
    68071-1672LISINOPRILLISINOPRIL
    68071-1775LISINOPRILLISINOPRIL
    68071-3064LISINOPRILLISINOPRIL
    68071-1894LISINOPRILLISINOPRIL
    68071-3220LISINOPRILLISINOPRIL
    68071-3113LISINOPRILLISINOPRIL
    68071-3122LISINOPRILLISINOPRIL
    68071-1931LisinoprilLisinopril
    68071-3070lisinoprillisinopril
    68071-3043LISINOPRILLISINOPRIL
    68071-3123LISINOPRILLISINOPRIL
    68071-3145LISINOPRILLISINOPRIL
    68071-3178LISINOPRILLISINOPRIL
    68071-4660LisinoprilLisinopril
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.